Revenue: The sum of all revenue fields included for a company's operating activities.
Genmab A/S (GNMSF) had Revenue of $715.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$715.00M |
$195.00M |
|
$42.00M |
|
$673.00M |
|
$527.00M |
|
$188.00M |
|
$56.00M |
|
$244.00M |
|
$244.00M |
|
$195.00M |
|
$195.00M |
|
$195.00M |
|
$195.00M |
|
$188.00M |
|
$204.00M |
|
63.73M |
|
63.93M |
|
$3.06 |
|
$3.05 |
|
| Balance Sheet Financials | |
$4.04B |
|
$145.00M |
|
$2.55B |
|
$6.59B |
|
$756.00M |
|
-- |
|
$534.00M |
|
$1.29B |
|
$5.30B |
|
$3.19B |
|
$5.30B |
|
66.20M |
|
| Cash Flow Statement Financials | |
$287.00M |
|
$-43.00M |
|
$-13.00M |
|
$1.38B |
|
$1.62B |
|
$239.00M |
|
$25.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.13% |
|
26.29% |
|
26.29% |
|
-- |
|
34.13% |
|
27.27% |
|
$275.00M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
3.50 |
|
0.89 |
|
100.57 |
|
3.68% |
|
6.12% |
|
2.96% |
|
3.68% |
|
$80.00 |
|
$4.30 |
|
$4.49 |
|